Facts Matter (Oct. 18): US Taxpayers Set to Pay $712 per Patient for Merck’s New COVID Pill

A new COVID-19 pill that can purportedly cut the risk of both hospitalization as well as death from COVID-19—by as much as 50 percent—is now in the process of getting emergency use authorization. However, according to several researchers, the technology that this pill uses runs the risk of potentially causing cancer, although, ...